What are the alternatives to Ativan (lorazepam) for treating anxiety and insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternatives to Ativan (Lorazepam) for Treating Anxiety and Insomnia

For patients requiring alternatives to Ativan (lorazepam) for anxiety and insomnia, the most effective options include non-benzodiazepine sedatives like eszopiclone, zaleplon, and zolpidem for insomnia, and buspirone for anxiety, as these medications offer similar efficacy with potentially fewer side effects and lower risk of dependence. 1, 2

For Insomnia Treatment

Non-Benzodiazepine Sedatives (Z-drugs)

  • Eszopiclone (2-3 mg): Recommended for both sleep onset and maintenance insomnia with better safety profile than benzodiazepines 1
  • Zaleplon (10 mg): Effective specifically for sleep onset insomnia with short half-life 1
  • Zolpidem (10 mg): Useful for both sleep onset and maintenance insomnia 1

Alternative Benzodiazepines

  • Temazepam (15-30 mg): Effective for sleep onset and maintenance with intermediate half-life; start with 7.5 mg in elderly patients 1
  • Triazolam (0.25 mg): Useful for sleep onset insomnia; short-acting 1

Other FDA-Approved Options

  • Ramelteon (8 mg): Melatonin receptor agonist effective for sleep onset insomnia; non-scheduled medication with no abuse potential 1
  • Suvorexant (10-20 mg): Orexin receptor antagonist recommended for sleep maintenance insomnia 1
  • Doxepin (3-6 mg): Low-dose tricyclic antidepressant effective for sleep maintenance insomnia 1

For Anxiety Treatment

Non-Benzodiazepine Anxiolytics

  • Buspirone (5 mg twice daily, maximum 20 mg three times daily): Takes 2-4 weeks to become effective but has significantly lower sedation potential compared to benzodiazepines 1, 3

Antidepressants with Anxiolytic Properties

  • Desipramine (10-25 mg in morning, max 150 mg): Tends to be activating and reduces apathy; lower risk for cardiotoxic effects 1
  • Nortriptyline (10 mg at bedtime, max 40 mg daily): More sedating, may be useful for patients with agitated anxiety and insomnia 1
  • Trazodone (25 mg daily, maximum 200-400 mg): Effective for anxiety with sedative properties, though not recommended as first-line for insomnia alone 1

For Acute Agitation/Severe Anxiety

Antipsychotics (for severe cases)

  • Olanzapine (2.5-5 mg): Effective for acute agitation; can cause sedation and orthostatic hypotension 1
  • Quetiapine (25 mg): Sedating with lower risk of extrapyramidal side effects 1

Important Considerations and Cautions

Medication Selection Factors

  • Patient's symptom profile (sleep onset vs. maintenance insomnia) should guide medication choice 2
  • Previous treatment responses and comorbid conditions significantly impact effectiveness 2
  • Consider half-life: shorter-acting medications for sleep onset problems, longer-acting for maintenance insomnia 1

Safety Concerns

  • Benzodiazepines carry risks of tolerance, addiction, depression, and cognitive impairment with regular use 1
  • Paradoxical agitation occurs in approximately 10% of patients treated with benzodiazepines 1
  • Non-benzodiazepine options generally have lower risk of dependence and fewer side effects 3
  • Lorazepam has been associated with rare cases of drug-induced liver injury 4

Administration Guidelines

  • Most sleep medications should be administered on an empty stomach for maximum effectiveness 1
  • Short-term use (2-4 weeks) is recommended for all sedative-hypnotics to minimize dependence 2
  • Dosage reduction is advised for elderly patients and those with hepatic impairment 1

Medications to Avoid

  • Diphenhydramine and other over-the-counter antihistamines: Limited efficacy for insomnia 1
  • Melatonin and L-tryptophan: Insufficient evidence for effectiveness in treating insomnia 1
  • Valerian: Not recommended due to variable dosages and limited efficacy 1
  • Tiagabine: Not recommended due to insufficient evidence and potential for significant side effects 1

By selecting appropriate alternatives to lorazepam based on the specific symptoms and patient characteristics, clinicians can effectively manage anxiety and insomnia while potentially reducing risks associated with benzodiazepine use.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Choosing the Right Benzodiazepine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lorazepam as a Cause of Drug-Induced Liver Injury.

Case reports in gastroenterology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.